These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 21397646)

  • 1. Electrically-assisted delivery of an anionic protein across intact skin: cathodal iontophoresis of biologically active ribonuclease T1.
    Dubey S; Kalia YN
    J Control Release; 2011 Jun; 152(3):356-62. PubMed ID: 21397646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive iontophoretic delivery of enzymatically active ribonuclease A (13.6 kDa) across intact porcine and human skins.
    Dubey S; Kalia YN
    J Control Release; 2010 Aug; 145(3):203-9. PubMed ID: 20423719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the poor iontophoretic transport of lysozyme across the skin: when high charge and high electrophoretic mobility are not enough.
    Dubey S; Kalia YN
    J Control Release; 2014 Jun; 183():35-42. PubMed ID: 24657950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive transdermal iontophoretic delivery of biologically active human basic fibroblast growth factor.
    Dubey S; Perozzo R; Scapozza L; Kalia YN
    Mol Pharm; 2011 Aug; 8(4):1322-31. PubMed ID: 21696184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal delivery of cytochrome C--A 12.4 kDa protein--across intact skin by constant-current iontophoresis.
    Cázares-Delgadillo J; Naik A; Ganem-Rondero A; Quintanar-Guerrero D; Kalia YN
    Pharm Res; 2007 Jul; 24(7):1360-8. PubMed ID: 17457661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of skin barrier impairment on the iontophoretic transport of low and high molecular weight permeants.
    Gratieri T; Zarhloule R; Dubey S; Kalia YN
    Int J Pharm; 2021 Jun; 602():120607. PubMed ID: 33862130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transdermal iontophoresis: modulation of electroosmosis by polypeptide.
    Hirvonen J; Guy RH
    J Control Release; 1998 Jan; 50(1-3):283-9. PubMed ID: 9685895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro permeability of a model protein across ocular tissues and effect of iontophoresis on the transscleral delivery.
    Tratta E; Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Biopharm; 2014 Sep; 88(1):116-22. PubMed ID: 24816128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Invasive Delivery of Negatively Charged Nanobodies by Anodal Iontophoresis: When Electroosmosis Dominates Electromigration.
    Sahraoui PF; Vadas O; Kalia YN
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific protein-protein interactions limit the cutaneous iontophoretic transport of interferon beta-1b and a poly-Arg interferon beta-1b analogue.
    Dubey S; Perozzo R; Scapozza L; Kalia YN
    Int J Pharm; 2020 Nov; 589():119913. PubMed ID: 32971174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil.
    Merino V; López A; Kalia YN; Guy RH
    Pharm Res; 1999 May; 16(5):758-61. PubMed ID: 10350021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of skin permeation of high molecular compounds by a combination of microneedle pretreatment and iontophoresis.
    Wu XM; Todo H; Sugibayashi K
    J Control Release; 2007 Apr; 118(2):189-95. PubMed ID: 17270306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical models to describe iontophoretic transport in vitro and in vivo and the effect of current application on the skin barrier.
    Gratieri T; Kalia YN
    Adv Drug Deliv Rev; 2013 Feb; 65(2):315-29. PubMed ID: 22626977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive targeted iontophoretic delivery of cetuximab to skin.
    Lapteva M; Sallam MA; Goyon A; Guillarme D; Veuthey JL; Kalia YN
    Expert Opin Drug Deliv; 2020 Apr; 17(4):589-602. PubMed ID: 32067504
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin.
    Sebastiani P; Nicoli S; Santi P
    Int J Pharm; 2005 Mar; 292(1-2):119-26. PubMed ID: 15725558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
    Bachhav YG; Heinrich A; Kalia YN
    Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the iontophoretic permselectivity properties of human and pig skin.
    Marro D; Guy RH; Delgado-Charro MB
    J Control Release; 2001 Jan; 70(1-2):213-7. PubMed ID: 11166421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iontophoretic delivery across the skin: electroosmosis and its modulation by drug substances.
    Hirvonen J; Guy RH
    Pharm Res; 1997 Sep; 14(9):1258-63. PubMed ID: 9327458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.